Business

Drug Company Sues Over Weight-Loss Drug

Updated 2026-08-12 13:25 UTC 1 source Negative

Eli Lilly is suing pharmacies and peptide vendors over the sale of its new weight-loss drug, retatrutide. The company claims unauthorized sales are infringing on its patents.

Coverage timeline — 2 articles

MarketWatch

Nebius adds to the excitement around neocloud stocks with upbeat earnings of its own

Investors are reacting positively to earnings results and demand signals from neocloud companies CoreWeave and Nebius.

2026-08-12 13:06 UTC

MarketWatch

Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.

2026-08-12 13:07 UTC